Olanzapine long-acting injection (LAI) is an investigational formulation that combines olanzapine, an atypical antipsychotic, with pamoic acid resulting in a salt that sustains the delivery of olanzapine for a period of up to four weeks.
What does LAI stand for?
LAI stands for Long-Acting Injection
This definition appears frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of LAI
We have 119 other meanings of LAI in our Acronym Attic
- Lean Aerospace Initiative
- Lesson Administration Instruction
- Ley de Acceso a la Información (Guatemala)
- Liberal Arts Institute (various locations)
- Library of Ancient Israel
- Light Armored Infantry
- Linear Antenna Impedance
- Local Access Infection
- Location Area Identification
- Logic and Artificial Intelligence
- Look Ahead Interflow
- Low Airspeed Indicator
- Lake Area Industry Alliance (est. 2000; Lake Charles, LA)
- Langile Abertzaleen Iraultzarako Alderdia (Spain)
- Latin American Integration Association
- Leukocyte Adherence Inhibitory Activity (immunology)
- Lung and Asthma Information Agency (St. George's Hospital Medical School; UK; est. 1990)
- Los Angeles Institute of Architecture and Design
- Los Angeles Institute for Art Therapy (California)
- Latin American Information Base (database)
Samples in periodicals archive:
4 /PRNewswire/ -- Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study.
NEW YORK, October 5 /PRNewswire/ -- Patients with schizophrenia or schizoaffective disorder taking risperidone long-acting injection were observed to have fewer psychiatric-related hospitalizations, and additionally fewer psychiatric-related inpatient days per month, improved antipsychotic medication compliance, and lower total monthly medical costs, compared to their experience prior to initiating treatment with risperidone long-acting injection.
The most common reasons for switching those patients to risperidone long-acting injection were non-compliance with previous medication, side effects or insufficient efficacy.